323 Preclinical development of AB-1015, an integrated circuit T cell therapy containing an ALPG/MSLN logic gate and FAS/PTPN2 shRNA-miR, for the treatment of ovarian cancer

• Irene Scarfò,
• Stephen Santoro,
• Aaron Cooper,
• Jun Feng,
• Dina Polyak,
• Michelle Nguyen,
• James Zhang,
• Hongruo Yun,
• Jasper Williams,
• Jessica Fuhriman,
• Jennifer McDevitt

Affiliations

Irene Scarfò

2Massachusettes General Hospital, Boston, MA, USA

Stephen Santoro

Arsenal Biosciences, South San Francisco, CA, USA

Aaron Cooper

Arsenal Biosciences, South San Francisco, CA, USA

Jun Feng

5 School of Global management, Hongik University, Seoul, Korea

Dina Polyak

2ArsenalBio, Palo Alto, CA, USA

Michelle Nguyen

Arsenal Biosciences, South San Francisco, CA, USA

James Zhang

Department of Medicine, 5841 S Maryland Ave, MC 5000, The University of Chicago, Chicago, Illinois, USA

Hongruo Yun

1ArsenalBio, South San Francisco, CA, USA

Jasper Williams

1ArsenalBio, South San Francisco, CA, USA

Jessica Fuhriman

1ArsenalBio, South San Francisco, CA, USA

Jennifer McDevitt

1ArsenalBio, South San Francisco, CA, USA